MBTPS1 and glomerular disorder: The data reported here suggest that targeting SK2 activity in this model of murine LN reduced progression of glomerular disease; however, targeting SK1 may prevent the accumulation of dh-S1P in kidney tissue and improve kidney pathology, albuminuria, and function.